Your browser doesn't support javascript.
loading
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT).
Ortí, Guillermo; Gras, Luuk; Koster, Linda; Kulagin, Aleksander; Byrne, Jenny; Apperley, Jane F; Halaburda, Kazimierz; Blau, Igor Wolfgang; Clark, Andrew; Kröger, Nicolaus; Griskevicius, Laimonas; Carlson, Kristina; Collin, Matthew; Bloor, Adrian; Raiola, Anna Maria; Blaise, Didier; Aljurf, Mahmoud; López-Corral, Lucia; Sakellari, Ioanna; Beguin, Yves; Wrobel, Tomasz; de Rosa, Luca; de Lavallade, Hughes; Hayden, Patrick J; McLornan, Donal; Chalandon, Yves; Yakoub-Agha, Ibrahim.
Afiliação
  • Ortí G; Department of Hematology, Vall d`Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. Electronic address: gorti@vhio.net.
  • Gras L; EBMT Statistical Unit, Leiden, the Netherlands.
  • Koster L; EBMT Leiden Study Unit, Leiden, the Netherlands.
  • Kulagin A; RM Gorbacheva Research Institute, Pavlov University, Petersburg, Russian Federation.
  • Byrne J; Nottingham University, Nottingham, United Kingdom.
  • Apperley JF; Imperial College, London, United Kingdom.
  • Halaburda K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Blau IW; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Clark A; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Kröger N; University Hospital Eppendorf, Hamburg, Germany.
  • Griskevicius L; Vilnius University Hospital, Vilnius, Lithuania.
  • Carlson K; University Hospital, Uppsala, Sweden.
  • Collin M; Northern Centre for Bone Marrow Transplantation, Newcastle Upon Tyne, United Kingdom.
  • Bloor A; Christie NHS Trust Hospital, Manchester, United Kingdom.
  • Raiola AM; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Blaise D; Programme de Transplantation & Therapie Cellulaire, Marseille, France.
  • Aljurf M; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • López-Corral L; Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Sakellari I; George Papanicolaou General Hospital, Thessaloniki, Greece.
  • Beguin Y; University of Liege and CHU of Liege, Liege, Belgium.
  • Wrobel T; Wroclaw Medical University, Wroclaw, Poland.
  • de Rosa L; Ospedale S. Camillo-Forlanini, Rome, Italy.
  • de Lavallade H; Guy's and St.Thomas' NHS Foundation Trust, London, United Kingdom.
  • Hayden PJ; St. James's Hospital, Trinity College, Dublin, Ireland.
  • McLornan D; University College Hospital, London, United Kingdom.
  • Chalandon Y; Hematology Division and Faculty of Medicine, Hôpitaux Universitaires de Genève, University of Geneva, Geneva, Switzerland.
  • Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France.
Transplant Cell Ther ; 30(1): 93.e1-93.e12, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37783337

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2024 Tipo de documento: Article